AMPK in Neurodegenerative Diseases (Q38998405)

8 September 2017

1 reference

title

AMPK in Neurodegenerative Diseases (English)

1 reference

8 September 2017

1 reference

Manon Domise

1 reference

8 September 2017

Valérie Vingtdeux

series ordinal

1 reference

8 September 2017

publication date

1 January 2016

1 reference

8 September 2017

1 reference

8 September 2017

volume

107

1 reference

8 September 2017

page(s)

153-177

1 reference

Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Skeletal muscle hexokinase: regulation in mammalian hibernation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Protein aggregation in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Single-cell imaging of bioenergetic responses to neuronal excitotoxicity and oxygen and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

"Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

DNA damage and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Why size matters - balancing mitochondrial dynamics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Energy metabolism in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

FDG PET in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Multiple Defects in Energy Metabolism in Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Deconstructing mitochondrial dysfunction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Linking calcium to Abeta and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Advanced Mitochondrial Respiration Assay for Evaluation of Mitochondrial Dysfunction in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrial defect in Huntington's disease caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Sestrin2 Protects Dopaminergic Cells against Rotenone Toxicity through AMPK-Dependent Autophagy Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Endurance factors improve hippocampal neurogenesis and spatial memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK agonist AICAR improves cognition and motor coordination in young and aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Metformin therapy in a transgenic mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Adenosinergic modulation of homocysteine-induced seizures in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Calcium and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Early alterations of brain cellular energy homeostasis in Huntington disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Autophagy failure in Alzheimer's disease—locating the primary defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Metabolic regulation of neuronal plasticity by the energy sensor AMPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Selective defect of in vivo glycolysis in early Huntington's disease striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

State of play in amyotrophic lateral sclerosis genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Genome-wide analysis of genetic loci associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrial trafficking and anchoring in neurons: New insight and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Drosophila alicorn is a neuronal maintenance factor protecting against activity-induced retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Adenosine monophosphate-activated protein kinase activation enhances embryonic neural stem cell apoptosis in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Axonal transport defects in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Role of 5'-adenosine monophosphate-activated protein kinase in cell survival and death responses in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Structure of mammalian AMPK and its regulation by ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Glucose regulates amyloid β production via AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

JNK3 perpetuates metabolic stress induced by Aβ peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

21 January 2018

Mechanisms of mitophagy

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Vesicular glycolysis provides on-board energy for fast axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

A comprehensive review of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mitochondrial abnormalities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-43589-3_7

Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis

31 March 2020

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1155/2014/483501

Identifiers

DOI

10.1007/978-3-319-43589-3_7

0 references

1 reference